GDRX logo

GoodRx Holdings, Inc. (GDRX)

Profile

Full Name

GoodRx Holdings, Inc.

Ticker

NASDAQ: GDRX

Exchange

NASDAQ

Sector

Healthcare

Industry

Health Information Services

Country

United States

IPO

September 23, 2020

Indexes

Not included

Website

http://www.goodrx.com

Employees

738

Key Details

Price

$5.00(+0.60%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$792.32M(+5.61% YoY)

Annual EPS

$0.04(+300.00% YoY)

PE ratio

62.50

Next earnings date

Aug 6, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $5.00
    GDRX price is $5.00

    30-Day Relative Volume

    0.43
    GDRX 30-day relative volume is 0.43

    Price Performance

    Price Most recent change

    +0.6%
    GDRX price was up +0.6% on Jul 25, 2025

    Price YTD change

    +7.53%
    GDRX price is up +7.53% since January 1st

    Price 1-year change

    -42.79%
    GDRX price is down -42.79% year-on-year

    Price 3-year change

    -24.36%
    GDRX price is down -24.36% over the past 3 years

    Price Range

    Price All-time high

    $64.22
    GDRX price is currently -92.21% below its historical high of $64.22

    Price 3-year low

    $3.67
    GDRX price is currently +36.05% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $1.79B
    GDRX market capitalization is $1.79 billion

    Market cap 3-year change

    -32.1%
    GDRX market capitalization is down -32.1% over the past 3 years

    Market cap All-time high

    $22.32B
    GDRX market capitalization is currently -92.00% below its historical high of $22.32 billion

    Market cap sector rank

    80.79%
    GDRX market capitalization is higher than 80.79% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    -5.66%
    GDRX shares outstanding is down -5.66% year-on-year

    Shares Outstanding 3-Year Change

    -10.24%
    GDRX shares outstanding is down -10.24% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.05
    GDRX beta is 1.05

    200-day SMA

    $4.81
    GDRX price is currently +3.95% above its 200-day simple moving average

    50-day SMA

    $4.47
    GDRX price is currently +11.81% above its 50-day simple moving average

    RSI

    60.32
    GDRX 14-day relative strength index is 60.32

    Volume

    0.43
    GDRX 30-day relative volume is 0.43

    ATR

    $0.16
    GDRX average true range is $0.16

    10-day Historical Volatility

    27.97%
    GDRX 10-day historical volatility is 27.97%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $792.32M
    GDRX annual revenue is $792.32 million

    Revenue Analysts estimate

    $819.81M
    GDRX annual revenue is currently -3.35% lower than the consensus analysts' forecast

    Revenue 1-year change

    +5.61%
    GDRX annual revenue is up +5.61% year-on-year

    Revenue Sector rank

    78.51%
    GDRX annual revenue is higher than 78.51% of companies in Healthcare sector

    EPS

    EPS

    $0.04
    GDRX annual earnings per share is $0.04

    EPS Analysts estimate

    $0.39
    GDRX annual earnings per share is currently -89.74% lower than the consensus analysts' forecast

    EPS 1-year change

    +300%
    GDRX annual earnings per share is up +300% year-on-year

    EPS Sector rank

    82.32%
    GDRX annual earnings per share is higher than 82.32% of companies in Healthcare sector

    Profit

    Gross profit

    $744.11M
    GDRX annual gross profit is $744.11 million

    Gross margin

    93.91%
    GDRX annual gross profit margin is 93.91%

    Operating profit

    $65.85M
    GDRX annual operating income is $65.85 million

    Operating margin

    8.31%
    GDRX annual operating profit margin is 8.31%

    Net income

    $16.39M
    GDRX annual net profit is $16.39 million

    Net margin

    2.07%
    GDRX annual net profit margin is 2.07%

    Expenses

    Total expenses

    $726.48M
    GDRX annual total expenses is $726.48 million

    Operating expenses

    $678.26M
    GDRX annual total operating expenses is $678.26 million

    Cost of goods sold

    $48.22M
    GDRX annual cost of goods sold is $48.22 million

    Selling, general & administrative expenses

    $484.98M
    GDRX annual SGA is $484.98 million

    Depreciation and amortization

    $69.54M
    GDRX annual depreciation & amortization is $69.54 million

    Interest expense

    $52.92M
    GDRX annual interest expense is $52.92 million

    Income tax

    $15.07M
    GDRX annual income tax is $15.07 million

    EBIT & EBITDA

    EBIT

    $84.38M
    GDRX annual earnings before interest & taxes is $84.38 million

    EBITDA

    $153.92M
    GDRX annual EBITDA is $153.92 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $1.39B
    GDRX annual total assets is $1.39 billion

    Non current assets

    $728.81M
    GDRX annual long term assets is $728.81 million

    Current assets

    $659.25M
    GDRX annual total current assets is $659.25 million

    Cash and cash equivalents

    $448.35M
    GDRX annual cash & cash equivalents is $448.35 million

    Accounts receivable

    $145.93M
    GDRX annual accounts receivable is $145.93 million

    Inventory

    -
    GDRX annual inventory value is unknown

    Liabilities

    Total liabilities

    $663.41M
    GDRX annual total liabilities is $663.41 million

    Long term liabilities

    $539.51M
    GDRX annual total long term liabilities is $539.51 million

    Current liabilities

    $123.90M
    GDRX annual total current liabilities is $123.90 million

    Accounts payable

    $14.14M
    GDRX annual accounts payable is $14.14 million

    Debt

    Total debt

    $543.39M
    GDRX annual total debt is $543.39 million

    Total debt 1-year change

    -23.58%
    GDRX annual total debt is down -23.58% year-on-year

    Long term debt

    $532.75M
    GDRX annual long term debt is $532.75 million

    Short term debt

    $10.64M
    GDRX annual short term debt is $10.64 million

    Equity & Capital

    Shareholders equity

    $724.66M
    GDRX annual stockholders equity is $724.66 million

    Book value

    $724.66M
    GDRX annual book value is $724.66 million

    Retained earnings

    -$1.44B
    GDRX annual retained earnings is -$1.44 billion

    Working capital

    $535.35M
    GDRX annual working capital is $535.35 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $183.89M
    GDRX annual cash flow from operations is $183.89 million

    Cash from operations 1-year change

    +32.97%
    GDRX annual cash flow from operations is up +32.97% year-on-year

    Cash from investing

    -$70.35M
    GDRX annual cash flow from investing activities is -$70.35 million

    Cash from investing 1-year change

    -26.15%
    GDRX annual cash flow from investing activities is down -26.15% year-on-year

    Cash from financing

    -$337.50M
    GDRX annual cash flow from financing activities is -$337.50 million

    Cash from financing 1-year change

    -101.62%
    GDRX annual cash flow from financing activities is down -101.62% year-on-year

    CAPEX

    CAPEX

    $70.35M
    GDRX annual capital expenditures is $70.35 million

    CAPEX 1-year change

    +26.15%
    GDRX annual capital expenditures is up +26.15% year-on-year

    Free Cash Flow

    Free cash flow

    $113.55M
    GDRX annual free cash flow is $113.55 million

    Free cash flow 1-year change

    +37.59%
    GDRX annual free cash flow is up +37.59% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    93.91%
    GDRX annual gross profit margin is 93.91%

    Operating margin

    8.31%
    GDRX annual operating profit margin is 8.31%

    Net margin

    2.07%
    GDRX annual net profit margin is 2.07%

    ROA & ROE

    ROA

    1.10%
    GDRX annual return on assets is 1.10%

    ROE

    2.21%
    GDRX annual return on equity is 2.21%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    62.50
    GDRX price to earnings ratio is 62.50

    PE ratio Sector rank

    86.79%
    GDRX price to earnings ratio is higher than 86.79% of companies in Healthcare sector

    PB Ratio

    PB ratio

    2.73
    GDRX price to book ratio is 2.73

    PB ratio Sector rank

    64.02%
    GDRX price to book ratio is higher than 64.02% of companies in Healthcare sector

    PS Ratio

    PS ratio

    2.24
    GDRX price to sales ratio is 2.24

    PS ratio Sector rank

    41.6%
    GDRX price to sales ratio is higher than 41.6% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $2.03B
    GDRX enterprise value is $2.03 billion

    Enterprise value Sector rank

    81.48%
    GDRX enterprise value is higher than 81.48% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    11.83
    GDRX EV/EBITDA is 11.83

    EV/EBITDA Sector rank

    85.04%
    GDRX EV/EBITDA is higher than 85.04% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    5.32
    GDRX annual current ratio is 5.32

    Quick ratio

    -
    GDRX annual quick ratio value is unknown

    Leverage

    Debt to equity

    0.68
    GDRX annual debt to equity ratio is 0.68

    Interest coverage ratio

    1.59
    GDRX annual interest coverage ratio is 1.59

    Risk & Stability

    Piotroski F-Score

    7
    GDRX piotroski f-score is 7

    Altman Z-Score

    1.40
    GDRX altman z-score is 1.40

    Analyst ratings

    Recent major analysts updates

    May 13, 25 UBS
    Neutral
    May 9, 25 Goldman Sachs
    Neutral
    Apr 29, 25 Wells Fargo
    Overweight
    Apr 10, 25 Truist Securities
    Hold
    Feb 28, 25 Wells Fargo
    Overweight
    Jan 10, 25 Citigroup
    Buy
    Jan 8, 25 Keybanc
    Overweight
    Dec 17, 24 Morgan Stanley
    Equal-Weight
    Nov 13, 24 Citigroup
    Buy
    Nov 11, 24 Barclays
    Overweight

    Institutional Ownership

    Screeners with GDRX included

    US stocks
    High Piotroski score stocks
    Stocks with high beta
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for GoodRx Holdings, Inc.?
    • Does GoodRx Holdings, Inc. pay dividends?
    • What sector is GoodRx Holdings, Inc. in?
    • What industry is GoodRx Holdings, Inc. in?
    • What country is GoodRx Holdings, Inc. based in?
    • When did GoodRx Holdings, Inc. go public?
    • Is GoodRx Holdings, Inc. in the S&P 500?
    • Is GoodRx Holdings, Inc. in the NASDAQ 100?
    • Is GoodRx Holdings, Inc. in the Dow Jones?
    • When was GoodRx Holdings, Inc.'s last earnings report?
    • When does GoodRx Holdings, Inc. report earnings?

    What is the ticker symbol for GoodRx Holdings, Inc.?

    The ticker symbol for GoodRx Holdings, Inc. is NASDAQ:GDRX

    Does GoodRx Holdings, Inc. pay dividends?

    No, GoodRx Holdings, Inc. does not pay dividends

    What sector is GoodRx Holdings, Inc. in?

    GoodRx Holdings, Inc. is in the Healthcare sector

    What industry is GoodRx Holdings, Inc. in?

    GoodRx Holdings, Inc. is in the Health Information Services industry

    What country is GoodRx Holdings, Inc. based in?

    GoodRx Holdings, Inc. is headquartered in United States

    When did GoodRx Holdings, Inc. go public?

    GoodRx Holdings, Inc.'s initial public offering (IPO) was on September 23, 2020

    Is GoodRx Holdings, Inc. in the S&P 500?

    No, GoodRx Holdings, Inc. is not included in the S&P 500 index

    Is GoodRx Holdings, Inc. in the NASDAQ 100?

    No, GoodRx Holdings, Inc. is not included in the NASDAQ 100 index

    Is GoodRx Holdings, Inc. in the Dow Jones?

    No, GoodRx Holdings, Inc. is not included in the Dow Jones index

    When was GoodRx Holdings, Inc.'s last earnings report?

    GoodRx Holdings, Inc.'s most recent earnings report was on May 7, 2025

    When does GoodRx Holdings, Inc. report earnings?

    The next expected earnings date for GoodRx Holdings, Inc. is August 6, 2025
    On this page